Product Information

VERAPAMIL SR 120 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $3.0441 per EA under NDC 52536088001. Its NADAC has been published 89 times since Mar 12, 2025.

FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL SR 120 MG CAPSULE

verapamil hydrochloride
$3.0441per EA

Strength

120 mg/1

NDC

52536088001

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019614

FDA Approved

5/29/1990

TE Code

AB

On Market Since

5/29/1990

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL SR 120 MG CAPSULE has been published 89 times since Mar 12, 2025, and over the history we have for it it has risen 175.8%. The table below summarizes its recorded NADAC range and movement.

Current price$3.0441 per EA
All-time high$3.0441 (Nov 18, 2026)
All-time low$0.9946 (Aug 20, 2025)
52-week high$3.0441
52-week low$1.2959
Median price$1.2971
Average price$1.5301
Largest weekly change+37.8% (Aug 19, 2026)
Weeks tracked89
Tracking sinceMar 12, 2025

Price History

1W

+4.4%

1M

+10.7%

3M

+30.6%

6M

+134.9%

1Y

+149.6%

3Y

N/A

5Y

N/A

All

+175.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VERAPAMIL SR 120 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 120 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $3.0441 per EA (NDC 52536088001), effective Nov 18, 2026.

How has the price of VERAPAMIL SR 120 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for VERAPAMIL SR 120 MG CAPSULE has risen 175.8%. It has been tracked across 89 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 120 MG CAPSULE?

Since Mar 12, 2025, the NADAC for VERAPAMIL SR 120 MG CAPSULE has ranged from a low of $0.9946 (Aug 20, 2025) to a high of $3.0441 (Nov 18, 2026), with a median of $1.2971 per EA.

Are there cheaper alternatives to VERAPAMIL SR 120 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL SR 120 MG CAPSULE, is $2.7493 per EA — about 10% below VERAPAMIL SR 120 MG CAPSULE.

Who manufactures VERAPAMIL SR 120 MG CAPSULE?

VERAPAMIL SR 120 MG CAPSULE (NDC 52536088001) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.